chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Heart rate increased, Wheezing
Clinical narrative: tightness of chest; wheezing; fast heart rate; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness of chest), WHEEZING (wheezing), HEART RATE INCREASED (fast heart rate) and DYSPNOEA (shortness of breath) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced CHEST DISCOMFORT (tightness of chest), WHEEZING (wheezing), HEART RATE INCREASED (fast heart rate) and DYSPNOEA (shortness of breath). At the time of the report, CHEST DISCOMFORT (tightness of chest), WHEEZING (wheezing), HEART RATE INCREASED (fast heart rate) and DYSPNOEA (shortness of breath) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-Mar-2021: No specific follow-up information recorded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Hypersomnia, Pain in extremity, Urinary incontinence
Clinical narrative: Accidental urination and she cant control/hold urine; Arm is a little bit sore; Sleeping a lot; This spontaneous case was reported by a consumer and describes the occurrence of URINARY INCONTINENCE (Accidental urination and she cant control/hold urine), PAIN IN EXTREMITY (Arm is a little bit sore) and HYPERSOMNIA (Sleeping a lot) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced URINARY INCONTINENCE (Accidental urination and she cant control/hold urine), PAIN IN EXTREMITY (Arm is a little bit sore) and HYPERSOMNIA (Sleeping a lot). At the time of the report, URINARY INCONTINENCE (Accidental urination and she cant control/hold urine), PAIN IN EXTREMITY (Arm is a little bit sore) and HYPERSOMNIA (Sleeping a lot) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Heart rate: elevated (High) Elevated.         No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-035903 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Palpitations
Clinical narrative: Both arms got red after receiving vaccine; Heart rate increased to 130; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Both arms got red after receiving vaccine) and PALPITATIONS (Heart rate increased to 130) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M20190A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced ERYTHEMA (Both arms got red after receiving vaccine) and PALPITATIONS (Heart rate increased to 130). On 09-Feb-2021, ERYTHEMA (Both arms got red after receiving vaccine) and PALPITATIONS (Heart rate increased to 130) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Malaise, Pain
Clinical narrative: Heart was racing; feeling sick and under the weather; bad body aches; headache; fever of 99.3F; bad chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches), HEADACHE (headache) and PYREXIA (fever of 99.3F) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches), HEADACHE (headache), PYREXIA (fever of 99.3F) and CHILLS (bad chills). On 05-Mar-2021, PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches) and PYREXIA (fever of 99.3F) had resolved. At the time of the report, HEADACHE (headache) and CHILLS (bad chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 99.3 f (High) 99.3 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs are blood pressure, cholesterol and thyroid medications. Treatment medications are Tylenol.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pyrexia
Clinical narrative: Heart was racing; feeling sick and under the weather; bad body aches; headache; fever of 99.3F; bad chills; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches), HEADACHE (headache) and PYREXIA (fever of 99.3F) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches), HEADACHE (headache), PYREXIA (fever of 99.3F) and CHILLS (bad chills). On 05-Mar-2021, PALPITATIONS (Heart was racing), MALAISE (feeling sick and under the weather), PAIN (bad body aches) and PYREXIA (fever of 99.3F) had resolved. At the time of the report, HEADACHE (headache) and CHILLS (bad chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 99.3 f (High) 99.3 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs are blood pressure, cholesterol and thyroid medications. Treatment medications are Tylenol.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: fever; headache; chills /teeth chattering so strong thought that her teeth may crack; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), HEADACHE (headache) and CHILLS (chills /teeth chattering so strong thought that her teeth may crack) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). 21-Feb-2021, the patient experienced CHILLS (chills /teeth chattering so strong thought that her teeth may crack). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, PYREXIA (fever), HEADACHE (headache) and CHILLS (chills /teeth chattering so strong thought that her teeth may crack) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Feb-2021, Body temperature: 101 (Inconclusive) 101 F. On 23-Feb-2021, Body temperature: 103 (Inconclusive) 103 F. On 24-Feb-2021, Body temperature: 103.6 (Inconclusive) 103.6 F. On 25-Feb-2021, Body temperature: 101 (Inconclusive) 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medicines was not reported by reporter For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia, Nausea
Clinical narrative: dizziness; mild headache that was light tightness around head; nausea; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (mild headache that was light tightness around head), NAUSEA (nausea) and MYALGIA (Muscle pain) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination.     The patient's past medical history included Cancer surgery (Patient had a lung cancer surgery recently).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), HEADACHE (mild headache that was light tightness around head), NAUSEA (nausea) and MYALGIA (Muscle pain). At the time of the report, DIZZINESS (dizziness), HEADACHE (mild headache that was light tightness around head), NAUSEA (nausea) and MYALGIA (Muscle pain) outcome was unknown.            Concomitant medications reported were Heart medication, Prostate medication, Tranquilizer (not specified). Treatment details included  Tylenol and an antihistamine taken prior to the vaccine (prophylactic).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Feeling cold, Myalgia, Swelling
Clinical narrative: Cold; Swelling; Muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold), SWELLING (Swelling), MYALGIA (Muscle pain) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, ASPIRIN [ACETYLSALICYLIC ACID], HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM (LIPITOR), BRIMONIDINE TARTRATE (ALPHAGAN P) and LATANOPROST (XALATAN) for an unknown indication.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced SWELLING (Swelling), MYALGIA (Muscle pain) and CHILLS (Chills). On 04-Mar-2021 at 11:00 AM, the patient experienced FEELING COLD (Cold). At the time of the report, FEELING COLD (Cold), SWELLING (Swelling), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 152/82 (High) Her blood pressure was 152/82.         Treatment details included aspirin and heating pad. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: HIVES; Warm at the injection site; Itchy at the injection site; Red circle at the injection site , with the shape of a pear; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (HIVES), VACCINATION SITE WARMTH (Warm at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE ERYTHEMA (Red circle at the injection site , with the shape of a pear) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced URTICARIA (HIVES), VACCINATION SITE WARMTH (Warm at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE ERYTHEMA (Red circle at the injection site , with the shape of a pear). At the time of the report, URTICARIA (HIVES), VACCINATION SITE WARMTH (Warm at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE ERYTHEMA (Red circle at the injection site , with the shape of a pear) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       patient reported using medications for diabetes concomitantly. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Pruritus, Tongue discomfort, Urticaria
Clinical narrative: Not a constriction in her throat that she felt with anaphylaxis.; Itching of the scalp; Extreme burning on the tip of the tongue; The hives on her back; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (The hives on her back), OROPHARYNGEAL DISCOMFORT (Not a constriction in her throat that she felt with anaphylaxis.), PRURITUS (Itching of the scalp) and TONGUE DISCOMFORT (Extreme burning on the tip of the tongue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy and Shellfish allergy.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced URTICARIA (The hives on her back). On an unknown date, the patient experienced OROPHARYNGEAL DISCOMFORT (Not a constriction in her throat that she felt with anaphylaxis.), PRURITUS (Itching of the scalp) and TONGUE DISCOMFORT (Extreme burning on the tip of the tongue). On 10-Feb-2021, OROPHARYNGEAL DISCOMFORT (Not a constriction in her throat that she felt with anaphylaxis.) had resolved. On 03-Mar-2021, URTICARIA (The hives on her back) had resolved. At the time of the report, PRURITUS (Itching of the scalp) and TONGUE DISCOMFORT (Extreme burning on the tip of the tongue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment reported.  Upon internal review on 21-May-2021, the age was corrected to unknown.   This case was linked to US-MODERNATX, INC.-MOD-2021-036127 (E2B Linked Report). This case was linked to MOD-2021-036029 (Patient Link).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-036127:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Therapeutic response unexpected
Clinical narrative: Arthritis in hands went away; Arthritis in hands went away; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis in hands went away) and THERAPEUTIC RESPONSE UNEXPECTED (Arthritis in hands went away) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced ARTHRITIS (Arthritis in hands went away) and THERAPEUTIC RESPONSE UNEXPECTED (Arthritis in hands went away). At the time of the report, ARTHRITIS (Arthritis in hands went away) had not resolved and THERAPEUTIC RESPONSE UNEXPECTED (Arthritis in hands went away) outcome was unknown.            Treatment information was not provided.  Concomitant product use was unknown by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: No new information was received and patient denied for further contact.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Syringe blew off and vaccine leaked out on the floor; Syringe blew off; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Syringe blew off and vaccine leaked out on the floor) and DEVICE CONNECTION ISSUE (Syringe blew off) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced UNDERDOSE (Syringe blew off and vaccine leaked out on the floor) and DEVICE CONNECTION ISSUE (Syringe blew off). On 05-Mar-2021, UNDERDOSE (Syringe blew off and vaccine leaked out on the floor) and DEVICE CONNECTION ISSUE (Syringe blew off) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.     Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: NNI; Reporter's Comments: This case concerns a 22-year-old male patient who received their first of two planned doses of mRNA-1273 (Lot #  unknown), reporting (device connection issue and underdose) without any associated adverse events. Event occurred the same day as vaccine administration. Events considered resolved.; Sender's Comments: same reporter, same event
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Fatigue, Nervousness, Pyrexia, Vulvovaginal discomfort
Clinical narrative: Tired; nervousness; Memory loss; had a little temperature; weird sensation in her vagina and thinks it might be a yeast infection; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired), NERVOUSNESS (nervousness), AMNESIA (Memory loss), PYREXIA (had a little temperature) and VULVOVAGINAL DISCOMFORT (weird sensation in her vagina and thinks it might be a yeast infection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027AG1A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 02-Mar-2021, the patient experienced FATIGUE (Tired), NERVOUSNESS (nervousness), AMNESIA (Memory loss), PYREXIA (had a little temperature) and VULVOVAGINAL DISCOMFORT (weird sensation in her vagina and thinks it might be a yeast infection). At the time of the report, FATIGUE (Tired), NERVOUSNESS (nervousness), AMNESIA (Memory loss), PYREXIA (had a little temperature) and VULVOVAGINAL DISCOMFORT (weird sensation in her vagina and thinks it might be a yeast infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise
Clinical narrative: headache; felt like run over by a diesel, she could not walk, she was not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt like run over by a diesel, she could not walk, she was not feeling well) and HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO HISTORICAL CONDITION REPORTED.).    On 22-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Feb-2021, the patient experienced MALAISE (felt like run over by a diesel, she could not walk, she was not feeling well). On 05-Mar-2021, the patient experienced HEADACHE (headache). On 24-Feb-2021, MALAISE (felt like run over by a diesel, she could not walk, she was not feeling well) had resolved. At the time of the report, HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were reported.  No treatment medication were provided.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site arm is sore; A spontaneous report was received from a health care professional concerning a 69-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed pain at vaccination site.    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, was not provided.     On 04 Mar 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot 032M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.      On unknown date, the patient developed pain at injection site  Treatment for the event was not provided.     Action taken with mRNA-1273 in response to the event was unknown.      The outcome of the event, pain at vaccination site was considered unknown.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fall, Nausea, Pyrexia
Clinical narrative: Fell down while washing hands at the sink; Dizziness; Weakness; Mild feverish; Mild nausea; Vomiting; Mild pain at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell down while washing hands at the sink), DIZZINESS (Dizziness), ASTHENIA (Weakness), PYREXIA (Mild feverish) and NAUSEA (Mild nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Hypothyroidism. Concomitant products included LISINOPRIL for Hypertension, LEVOTHYROXINE for Hypothyroidism.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FALL (Fell down while washing hands at the sink), DIZZINESS (Dizziness), ASTHENIA (Weakness), PYREXIA (Mild feverish), NAUSEA (Mild nausea), VOMITING (Vomiting) and VACCINATION SITE PAIN (Mild pain at the site of the injection). At the time of the report, FALL (Fell down while washing hands at the sink), DIZZINESS (Dizziness), ASTHENIA (Weakness), PYREXIA (Mild feverish), NAUSEA (Mild nausea), VOMITING (Vomiting) and VACCINATION SITE PAIN (Mild pain at the site of the injection) had resolved.            No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Follow up received on 01 May 2021. The event outcome updated as recovered.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Fell down while washing hands at the sink; Dizziness; Weakness; Mild feverish; Mild nausea; Vomiting; Mild pain at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell down while washing hands at the sink), DIZZINESS (Dizziness), ASTHENIA (Weakness), PYREXIA (Mild feverish) and NAUSEA (Mild nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Hypothyroidism. Concomitant products included LISINOPRIL for Hypertension, LEVOTHYROXINE for Hypothyroidism.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FALL (Fell down while washing hands at the sink), DIZZINESS (Dizziness), ASTHENIA (Weakness), PYREXIA (Mild feverish), NAUSEA (Mild nausea), VOMITING (Vomiting) and VACCINATION SITE PAIN (Mild pain at the site of the injection). At the time of the report, FALL (Fell down while washing hands at the sink), DIZZINESS (Dizziness), ASTHENIA (Weakness), PYREXIA (Mild feverish), NAUSEA (Mild nausea), VOMITING (Vomiting) and VACCINATION SITE PAIN (Mild pain at the site of the injection) had resolved.            No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Follow up received on 01 May 2021. The event outcome updated as recovered.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.    This case was linked to MOD-2021-035979 (Patient Link).   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nausea
Clinical narrative: bad side effects in their muscles, joints and is nauseas; joints; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (bad side effects in their muscles, joints and is nauseas), ARTHRALGIA (joints) and NAUSEA (nauseas) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced MYALGIA (bad side effects in their muscles, joints and is nauseas), ARTHRALGIA (joints) and NAUSEA (nauseas). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, MYALGIA (bad side effects in their muscles, joints and is nauseas), ARTHRALGIA (joints) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives after receiving the modern vaccine; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives after receiving the modern vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives after receiving the modern vaccine). At the time of the report, URTICARIA (Hives after receiving the modern vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.    This case was linked to MOD-2021-035672 (Patient Link).
Sex: M
Vaccine: COVID19, UNK
Symptoms: Arthralgia, Chills, Fatigue
Clinical narrative: Fatigue; Joint aches like flu; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), ARTHRALGIA (Joint aches like flu) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for an unknown indication.    No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On 11-Feb-2021, the patient experienced FATIGUE (Fatigue), ARTHRALGIA (Joint aches like flu) and CHILLS (Chills). On 11-Feb-2021, FATIGUE (Fatigue), ARTHRALGIA (Joint aches like flu) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Rash
Clinical narrative: really sore arm; itchy; bad rash over her body; really red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really sore arm), RASH (bad rash over her body), PRURITUS (itchy) and ERYTHEMA (really red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ERYTHEMA (really red). On an unknown date, the patient experienced PAIN IN EXTREMITY (really sore arm), RASH (bad rash over her body) and PRURITUS (itchy). At the time of the report, PAIN IN EXTREMITY (really sore arm), RASH (bad rash over her body), PRURITUS (itchy) and ERYTHEMA (really red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Vitamins   Treatment information included Benadryl  oral and cortisone cream    This case was linked to MOD-2021-036525, MOD-2021-036546 (Patient Link).
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Massive red rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Massive red rash) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Massive red rash). At the time of the report, RASH ERYTHEMATOUS (Massive red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's friend after reporting ADR continued as "I will be bringing her to her dr. I will be sending you the bill. Now this is everyone I know. You very well knew there were severe reactions. You knew and lied. Thanks a bunch"
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram, Therapeutic response unexpected
Clinical narrative: burning pain in chest at the site of tumors; CAT scan from 2Mar2021 showed significant regression of tumors; This spontaneous case was reported by a health care professional and describes the occurrence of CHEST PAIN (burning pain in chest at the site of tumors) and COMPUTERISED TOMOGRAM (CAT scan from 2Mar2021 showed significant regression of tumors) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0262Z0A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (burning pain in chest at the site of tumors) and COMPUTERISED TOMOGRAM (CAT scan from 2Mar2021 showed significant regression of tumors). At the time of the report, CHEST PAIN (burning pain in chest at the site of tumors) and COMPUTERISED TOMOGRAM (CAT scan from 2Mar2021 showed significant regression of tumors) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Computerised tomogram: significant regression of tumors (Inconclusive) significant regression of tumors.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Oxygen saturation, Palpitations
Clinical narrative: heart racing and palpitations; palpitations; This spontaneous case was reported by a health care professional and describes the occurrence of PALPITATIONS (heart racing and palpitations) and PALPITATIONS (palpitations) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included GLIPIZIDE for Diabetes, NEBIVOLOL for Hypertension.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PALPITATIONS (heart racing and palpitations) and PALPITATIONS (palpitations). At the time of the report, PALPITATIONS (heart racing and palpitations) and PALPITATIONS (palpitations) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Blood pressure measurement: 135/80, mmHg abnormal, 150/80 mmHg abnormal and 136/86 mmHg abnormal. On 11-Feb-2021, Heart rate: 75 beats/ second (normal) Normal, 71 beats/ second (normal) Normal and 64 beats/ second (normal) Normal. On 11-Feb-2021, Oxygen saturation: 97 % (normal) Normal, 96 % (normal) Normal and 96 % (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication reported
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Rash macular
Clinical narrative: Slightly Higher Temperature; red blotches down arm of vaccine that itches like crazy; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (Slightly Higher Temperature) and RASH MACULAR (red blotches down arm of vaccine that itches like crazy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (Slightly Higher Temperature) and RASH MACULAR (red blotches down arm of vaccine that itches like crazy). At the time of the report, BODY TEMPERATURE INCREASED (Slightly Higher Temperature) and RASH MACULAR (red blotches down arm of vaccine that itches like crazy) outcome was unknown.     No treatment information was provided.  No relevant concomitant medications reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Feeling hot, Tenderness
Clinical narrative: back pain; arm was tender; arm was warm; hip pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), TENDERNESS (arm was tender), FEELING HOT (arm was warm) and ARTHRALGIA (hip pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced BACK PAIN (back pain), TENDERNESS (arm was tender), FEELING HOT (arm was warm) and ARTHRALGIA (hip pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (back pain) and TENDERNESS (arm was tender) had not resolved and FEELING HOT (arm was warm) and ARTHRALGIA (hip pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Inappropriate schedule of product administration, SARS-CoV-2 test
Clinical narrative: More than 36 days have passed since getting first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have passed since getting first dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have passed since getting first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have passed since getting first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, Antibody test: 250.00 (Positive) came out greater than 250.00 and it was positive. On 04-May-2021, SARS-CoV-2 test: (Negative) negative. On 03-Aug-2021, Antibody test: 3110.2 (Positive) came back as positive again. On 03-Aug-2021, SARS-CoV-2 test: (Negative) negative.         No treatment medications were provided.   This case was linked to MOD-2021-037732 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: dose 2 regimen added in product tab, action taken changed to not applicable On 09-Aug-2021: Date of dose 2 vaccination was updated.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, lot #: 037K20A with no associated AEs.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic neuritis, Anxiety, Hypoacusis, Otosalpingitis
Clinical narrative: anxiety; Acoustic Neuritis; didn't hear/TV sounded awful like "blur blur", no recognition off any words, just garbled mess, it lasted the whole night; Acute Eustachian Salpingitis/ears started to feel funny going to my throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOACUSIS (didn't hear/TV sounded awful like "blur blur", no recognition off any words, just garbled mess, it lasted the whole night), OTOSALPINGITIS (Acute Eustachian Salpingitis/ears started to feel funny going to my throat), ACOUSTIC NEURITIS (Acoustic Neuritis) and ANXIETY (anxiety) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Product used for unknown indication, BIMATOPROST (LUMIGAN PF), LANSOPRAZOLE, COLECALCIFEROL (VIT D3), CYANOCOBALAMIN (VIT B12), IBUPROFEN, GABAPENTIN, FAMOTIDINE, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE (KLOR CON), DICLOFENAC SODIUM, DOCUSATE SODIUM (STOOL SOFTENER), MILK OF MAGNESIA and VALSARTAN for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HYPOACUSIS (didn't hear/TV sounded awful like "blur blur", no recognition off any words, just garbled mess, it lasted the whole night) and OTOSALPINGITIS (Acute Eustachian Salpingitis/ears started to feel funny going to my throat). On 20-Feb-2021, the patient experienced ACOUSTIC NEURITIS (Acoustic Neuritis). On an unknown date, the patient experienced ANXIETY (anxiety). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency; GABAPENTIN at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPOACUSIS (didn't hear/TV sounded awful like "blur blur", no recognition off any words, just garbled mess, it lasted the whole night), OTOSALPINGITIS (Acute Eustachian Salpingitis/ears started to feel funny going to my throat), ACOUSTIC NEURITIS (Acoustic Neuritis) and ANXIETY (anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash, Rash macular
Clinical narrative: "big red blotch"; Itching; rash under left breast/delayed rash reaction under her right breast; fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR ("big red blotch"), PRURITUS (Itching), RASH (rash under left breast/delayed rash reaction under her right breast) and PYREXIA (fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included a right-side partial mastectomy (Past medical History includes a right-side partial mastectomy). Concurrent medical conditions included Hypertension, High cholesterol, Sinus Irritations (current medical history includes Sinus Irritations), Allergic to Darvocet and narcotics (Allergic to Darvocet) and Allergy (Allergic to narcotics (with Tylenol).). Concomitant products included LISINOPRIL, ATORVASTATIN and MONTELUKAST for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MACULAR ("big red blotch"), PRURITUS (Itching), RASH (rash under left breast/delayed rash reaction under her right breast) and PYREXIA (fever). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) (topical) at an unspecified dose and frequency and BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORIN TOPICAL) at an unspecified dose and frequency. At the time of the report, RASH MACULAR ("big red blotch"), PRURITUS (Itching) and RASH (rash under left breast/delayed rash reaction under her right breast) outcome was unknown and PYREXIA (fever) had resolved.            Treatment History includes showers, and applying Cortisone cream and Topical Neosporin (with pain reliever).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Retching
Clinical narrative: Arm soreness; Dry heaves; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), RETCHING (Dry heaves) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), RETCHING (Dry heaves) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of Thursday afternoon. At the time of the report, PAIN IN EXTREMITY (Arm soreness), RETCHING (Dry heaves) and NAUSEA (Nausea) outcome was unknown.            This case was linked to MOD-2021-036177 (Patient Link).